Stock Events

Sangamo Therapeutics (SGMO) Q3 2024 Earnings

SGMO -2.16%
6AugConfirmed
Q3 2023
Q4 2023
Q2 2024
Q3 2024
-0.59
-0.44
-0.29
-0.15

Details

Expected EPS
-0.146729
Actual EPS
-0.18
Surprise EPS
-0.03
Surprise Percent
+22.68%

Description

Sangamo Therapeutics (SGMO) has reported earnings of -0.18 per share for Q3 2024.

0 Comments

Share your thoughts